As shown in Figure 4C–4E, only the expression of CCL1, IFNA21 and USP18 from nine prognostic immune genes was significantly different between EN and LN DLBCL by the Wilcoxon test (P < 0.05). This evidence concerns the gene USP18 and diffuse large B-cell lymphoma.